Investor

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

New exchange: Nasdaq First North

Calendar & Events

FluoGuide present at Økonomisk Ugebrev Life Science Investor Conference

10. marts 2021

January – March 2021 (Q1)

26 May 2021

Target release time before 9.00 AM

Half-year report (Q2)

25 August 2021

Target release time before 9.00 AM

January - September 2021 (Q3)

24 November 2021

Target release time before 9.00 AM